Melatonin attenuates scopolamine-induced cognitive dysfunction through SIRT1/IRE1α/XBP1 pathway.
Xiao-Qi LiuShun HuangJia-Yi ZhengCan WanTian HuYe-Feng CaiQi WangShi-Jie ZhangPublished in: CNS neuroscience & therapeutics (2024)
These results indicated that melatonin could ameliorate SCOP-induced cognitive dysfunction through the SIRT1/IRE1α/XBP1 pathway. SIRT1 might be the critical target of melatonin in the treatment of dementia.